Skip to main content

Month: February 2025

DIAGNOS Announces Amendment to Convertible Debentures

BROSSARD, Quebec, Feb. 28, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a leader in early detection of critical health issues using advanced Artificial Intelligence (AI), announces that it intends to amend the terms of an aggregate amount of $590,000 of unsecured convertible debentures (each a “Debenture”) issued as part of a private placement of units initially announced on March 1, 2022, as follows:The maturity date, initially set for March 1, 2025, is extended to March 1, 2026, and The yearly interest rate is increased from 8% to 10% for the extended period from March 1, 2025 to March 1, 2026.All other provisions of the Debentures will remain unchanged and fully in effect during the extension period. The amendment remains subject to the TSX Venture Exchange...

Continue reading

Kaldvik AS enters into definitive agreements to acquire key assets in the fish farming value chain on the east-coast of Iceland

Frøya, Norway, 27 February 2025: Reference is made to the announcement by Kaldvik AS (“Kaldvik”, the “Company”) on 20 December 2024 regarding a potential acquisition of certain key assets in the fish farming value chain on the east-coast of Iceland, from Heimstø AS (“Heimstø”) and Osval ehf. (“Osval”). Kaldvik has today entered into definitive agreements to acquire (i) 100% of the shares in Mossi ehf., which owns the property and building hosting Djupskel efh. (“Mossi”), from Heimstø, (ii) 100% of the shares in Djupskel ehf., the producer of fish boxes in Djupivogur (“Djupskel”), from Osval, a company owned by Heimstø (53.6%) and Osnes ehf. (46.4%) and (iii) 33.3% of the shares in Bulandstindur ehf., the fish processing facility in Djupivogur (“Bulandstindur”),...

Continue reading

EverCommerce Presents at the Citizens JMP Tech Conference

DENVER, Feb. 28, 2025 (GLOBE NEWSWIRE) — EverCommerce Inc. (NASDAQ: EVCM), a leading service commerce platform, today announced that management will present at the following upcoming investor conferences:Chief Executive Officer of EverHealth Evan Berlin and SVP & Head of Investor Relations Brad Korch will present at the Citizens JMP Technology Conference in San Francisco. The presentation is scheduled for Monday, March 3, 2025, at 11:30 a.m. PST.The links to the live webcasts for the conferences will be made available through the Investor Relations section of the Company’s website at: https://investors.evercommerce.com. About EverCommerce EverCommerce (Nasdaq: EVCM) is a leading service commerce platform, providing vertically-tailored, integrated SaaS solutions that help more than 690,000 global service-based businesses...

Continue reading

Consolidated Unaudited Interim Report of AS PRFoods for the 2nd quarter and 6 months of 2024/2025 financial year

MANAGEMENT COMMENTARY We can confirm that the second quarter of the financial year has been successful for the Group. The traditionally strong Christmas period has also contributed to a notable increase in sales for our production units. We extend our gratitude to our sales teams in both Estonia and the United Kingdom for their efforts. In the second quarter, the Group’s revenue was 6.8 million euros, rising from 5.4 million euros or 26% compared to last year’s same period. The gross profit for Q2 grew from 1.6 million euros to 1.7 million euros, while EBITDA from operations increased by 20%, from 0.5 million euros to 0.6 million euros. Compared to the previous financial year’s second quarter, the operating loss turned into an operating profit of 0.4 million euros. Additionally, the Group’s net loss for Q2 significantly decreased...

Continue reading

Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy

Tevogen Bio is focused on delivering affordable, safe, and easy-to-administer T cell therapies. The company’s ExacTcell™ technology enabled a proof-of-concept trial with highly positive results, published in Blood Advances. A key step in making therapies more accessible was the launch of Tevogen.AI and a partnership with Microsoft.WARREN, N.J., Feb. 28, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, announced today that its Founder and CEO, Ryan Saadi, MD, MPH, has been named to the 2025 NJBIZ Power 100, recognizing the most influential figures shaping New Jersey’s business landscape. The editorial team at NJBIZ highlights honorees as strategic leaders and innovators who drive progress and represent the state’s diversity. Dr....

Continue reading

Six Coherent Products Receive Awards From Lightwave + BTR Innovation Reviews for Excellence in Optical Networking

PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in high-performance optical networking solutions, proudly announces that six of its products received awards in the 2025 Lightwave + BTR Innovation Reviews. “Innovation is at the heart of everything we do, and this recognition underscores our commitment to technology leadership,” said Dr. Julie Eng, Chief Technology Officer at Coherent. “We are honored that six of our products have been recognized in the 2025 Lightwave + BTR Innovation Reviews, a testament to our team’s deep technical expertise and the impact of our solutions in the industry.” The following products were recognized: 200G Differential Electro-absorption Modulated Laser (D-EML): The 200G Differential Electro-absorption Modulated Laser (D-EML) was...

Continue reading

Akropolis Group has launched a Green Finance Framework that has received a positive assessment

Akropolis Group has launched a Green Finance Framework (the “Framework”), which allows for an even closer link between the company’s sustainability objectives and its financial activities. The Framework provides an opportunity to finance or refinance projects meeting the sustainability criteria set out in the Framework, including green buildings, through a variety of Green Finance Instruments. The Framework provides clear requirements for financed or refinanced projects, for example, buildings must have at least “Very Good” certificate according to the international BREEAM building sustainability standard or be among 15% of the most efficient buildings in the country in terms of energy performance. The Framework has been launched in accordance with best international practices and is in line with the Green Bond Principles (2021), including...

Continue reading

NOTICE TO DISREGARD — Armlogi Holding Corp.

WALNUT, CA, Feb. 28, 2025 (GLOBE NEWSWIRE) — We are advised by Armlogi Holding Corp. that journalists and other readers should disregard the news release “Armlogi Reports Increased shipping volume with Temu Sellers” issued February 28, 2025 over GlobeNewswire. Company Contact:info@armlogi.com Investor Relations Contact:Matthew Abenante, IRCPresidentStrategic Investor Relations, LLCTel: 347-947-2093Email: matthew@strategic-ir.com

Continue reading

NOTICE TO DISREGARD — Armlogi Holding Corp.

WALNUT, CA, Feb. 28, 2025 (GLOBE NEWSWIRE) — We are advised by Armlogi Holding Corp. that journalists and other readers should disregard the news release “Armlogi Reports Significant Progress and Enhanced Integration with the Temu Platform” issued October 10, 2024 over GlobeNewswire. Company Contact:info@armlogi.com Investor Relations Contact:Matthew Abenante, IRCPresidentStrategic Investor Relations, LLCTel: 347-947-2093Email: matthew@strategic-ir.com

Continue reading

NOTICE TO DISREGARD — Armlogi Holding Corp.

WALNUT, CA, Feb. 28, 2025 (GLOBE NEWSWIRE) — We are advised by Armlogi Holding Corp. that journalists and other readers should disregard the news release “Armlogi Becomes an official Authorized Warehouser for Temu Sellers” issued June 5, 2024 over GlobeNewswire. Company Contact:info@armlogi.com Investor Relations Contact:Matthew Abenante, IRCPresidentStrategic Investor Relations, LLCTel: 347-947-2093Email: matthew@strategic-ir.com

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.